Sort
23,748 grants matching “melanoma”
Mechanisms of Macrophage Functional Switch during Skin Repair
$171,784Francesco Marangoni · University Of California-Irvine · R21 · FY2019 · AR
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
$171,720Seth M Pollack · Fred Hutchinson Cancer Research Center · K23 · FY2017 · CA
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
$171,720Seth M Pollack · Fred Hutchinson Cancer Research Center · K23 · FY2015 · CA
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
$171,720Seth M Pollack · Fred Hutchinson Cancer Research Center · K23 · FY2016 · CA
Adoptive T cell Therapy for Patients with NY-ESO-1 Expressing Sarcomas
$171,720Seth M Pollack · Fred Hutchinson Cancer Research Center · K23 · FY2014 · CA
Molecular Modifiers of Endometrial Endometrioid Adenocarcinoma Immune Microenvironment: Impact of PTEN loss and CD73-Generated Adenosine Loss
$171,701Russell R Broaddus · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
Merkel cell polyomavirus infection and the host immune response
$171,694Jianxin You · University Of Pennsylvania · R21 · FY2020 · AR
IMMUNOBIOLOGY OF MALIGNANT GLIOMA
$171,651Gavin Peter Dunn · Washington University · K08 · FY2016 · NS
IMMUNOBIOLOGY OF MALIGNANT GLIOMA
$171,651Gavin Peter Dunn · Washington University · K08 · FY2015 · NS
Improving Symptom Management for Survivors of Young Adult Cancer
$171,642Caroline Dorfman · Duke University · K08 · FY2022 · CA
CANCER AND LEUKEMIA GROUP B
$171,639University Of Missouri-Columbia · U10 · FY2001 · CA
Specimen Resource Core
$171,507Ruth Halaban · Yale University · P50 · FY2013 · CA
(PQ8) Biomarker identification by mass cytometry in peripheral blood of patients with renal cell carcinoma undergoing immune checkpoint therapy
$171,499Wendy Jane Fantl · Stanford University · R21 · FY2020 · CA
Establishing bioactive serum and toxicity levels for Nanolipolee-007
$171,485Arati Sharma · Melanovus Oncology, Inc. · R43 · FY2012 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$171,480Gary Fanger · Rise Therapeutics, Llc · R44 · FY2024 · CA
Parallel Selective Capture of Single Circulating Melanoma Cells and Integrated On-Chip Determination of Mutational Status
$171,459Robbyn Kimberly Anand · Iowa State University · R21 · FY2021 · EB
Improving Symptom Management for Survivors of Young Adult Cancer
$171,444Caroline Dorfman · Duke University · K08 · FY2023 · CA
The CSBC Research Center for Cancer Systems Immunology at MSKCC
$171,400Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
SOUTHWEST ONCOLOGY GROUP
$171,365University Of Southern California · U10 · FY2000 · CA
CANCER AND LEUKEMIA GROUP B (CALGB)
$171,315Dartmouth College · U10 · FY2000 · CA
NEUROPATHOLOGY/TISSUE BANK CORE
$171,274Claudia Katharina Petritsch · Stanford University · U54 · FY2021 · CA
Gene-engineered adoptive T cell immunotherapy of GBM
$171,253Laura A Johnson · University Of Pennsylvania · DP2 · FY2015 · CA
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
$171,205Scott J Antonia · H. Lee Moffitt Cancer Ctr & Res Inst · K24 · FY2011 · CA
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
$171,205Scott J Antonia · H. Lee Moffitt Cancer Ctr & Res Inst · K24 · FY2012 · CA
cAMP signaling in melanoma pathogenesis: Evidence for multiple microdomains playi
$171,180Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · K08 · FY2014 · CA